https://www.selleckchem.com/pr....oducts/e7766-diammon
005) and 1.3 times (р=0.05 respectively, BMD R3 did not differ from the group with normal BMD. Conclusions The use of highly porous titanium cups TTM in patients with low bone mass did not lead to a bone loss in DeLee and Charnley periacetabular zones one year after THA. Consequently, the use of these cups in patients with low bone mass undergoing THA is a valuable treatment option. Conclusions The use of highly porous titanium cups TTM in patients with low bone mass did not lead to a bone loss in DeLee and Charnley peri
Beğen
Yorum Yap
Paylaş
